sharecast

{{ storiesRelated.title }}

AstraZeneca (AZN)

10,568.00p

17:15 12/12/24

  • 0.28% 30.00p
  • Today's Low & High
  • 10,468.00 / 10,576.00
  • Open / Previous Close
  • 10,544.00 / 10,568.00
  • 52-week range
  • 3.89% 396.00p
  • Volume
  • 1,500,307
  • Market Cap(billion)
  • £163.84b

KEY FINANCIALS

  Latest Forecast
Div Yield 2.2% n/a
Div Cover 1.3 n/a
Op Mrgn 17.9% n/a
ROCE 62.6%  
  Latest Forecast
P/E 34.9 n/a
PEG 0.4 n/a
Price / Revenue 4.5 n/a
Price / Book value 5.3  
  Latest Forecast
Revenue 3.3% 4.5%
PBT 175.8% n/a
EPS 81.1% -6.3%
DPS 0.0% -3.6%

KEY FUNDAMENTALS

Year Ending Revenue
($m)		 Pre-tax
($m)		 EPS P/E PEG EPS Growth Div Yield
2019-12-31 24,384.00 1,548.00 $1.03 97.9 -2.5 -39% $2.80 2.8%
2020-12-31 26,617.00 3,916.00 $2.44 41.0 0.3 137% $2.80 2.8%
2021-12-31 37,417.00 -265.00 $0.08 1,467.0 -15.2 -97% $2.87 2.4%
2022-12-31 44,351.00 2,501.00 $2.12 64.0 0.0 2,550% $2.90 2.1%
2023-12-31 45,811.00 6,899.00 $3.84 35.2 0.4 81% $2.90 2.1%

Latest Webfg News

AstraZeneca cancer drug secures US approval Sharecast News 05 Dec
AstraZeneca appoints Iskra Reic as vice-president of intl unit Sharecast News 04 Dec
AstraZeneca reports positive results from prostate cancer trial Sharecast News 25 Nov

Regulatory News

Imfinzi approved in US for limited-stage SCLC 05-Dec-24 07:02
AstraZeneca appoints Iskra Reic EVP International 04-Dec-24 13:45
Block listing Interim Review 02-Dec-24 15:05
Total Voting Rights 02-Dec-24 15:00
Truqap improved rPFS in advanced prostate cancer 25-Nov-24 07:01